1. Academic Validation
  2. Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor

Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor

  • J Med Chem. 2016 Oct 13;59(19):8848-8858. doi: 10.1021/acs.jmedchem.6b00676.
Saleem Ahmad 1 William N Washburn 1 Andres S Hernandez 1 Sharon Bisaha 1 Khehyong Ngu 1 Wei Wang 1 Mary Ann Pelleymounter 1 Daniel Longhi 1 Neil Flynn 1 Anthony V Azzara 1 Kenneth Rohrbach 1 James Devenny 1 Suzanne Rooney 1 Michael Thomas 1 Susan Glick 1 Helen Godonis 1 Susan Harvey 1 Hongwei Zhang 1 Brian Gemzik 1 Evan B Janovitz 1 Christine Huang 1 Lisa Zhang 1 Jeffrey A Robl 1 Brian J Murphy 1
Affiliations

Affiliation

  • 1 Metabolic Diseases Chemistry, ‡Metabolic Diseases Biology, §PCO MAP, ∥PCO Discovery Toxicology, and ⊥PCO Bioanalytical Research, Bristol-Myers Squibb Research & Development , P.O. Box 4000, Princeton, New Jersey 08543, United States.
Abstract

The potent MCHR1 in vitro and in vivo antagonist activity of a series of cyclic tertiary alcohols derived from compound 2b is described. Subsequent pharmacokinetic and pharmacodynamic studies identified BMS-814580 (compound 10) as a highly efficacious antiobesity agent with a relatively clean in vitro and in vivo safety profile.

Figures
Products